Crystalline forms of potassium channel modulators

Provided herein are crystalline and amorphous forms of a compound having structural formula (1). Also provided are pharmaceutical compositions comprising the crystalline and amorphous forms, methods for their manufacture, and uses thereof for treating a variety of diseases, disorders or conditions,...

Full description

Saved in:
Bibliographic Details
Main Authors Xu, Jun, Keaney, Gregg F, Xue, Wenfeng
Format Patent
LanguageEnglish
Published 28.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are crystalline and amorphous forms of a compound having structural formula (1). Also provided are pharmaceutical compositions comprising the crystalline and amorphous forms, methods for their manufacture, and uses thereof for treating a variety of diseases, disorders or conditions, associated with potassium channels.
Bibliography:Application Number: US201917287907